Darón I. Freedberg

Dr. Darón I. Freedberg

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2014 in Annual Review of Biophysics
Verified
Journal Article
Closed access
DFDarón I. Freedberg
Darón I. Freedberg
PSPhilipp Selenko
Philipp Selenko
Ever since scientists realized that cells are the basic building blocks of all life, they have been developing tools to look inside them to reveal the architectures and mechanisms that define their biological functions. Whereas “looking into cells” is typically said in reference to optical microscopy, high-resolution in-cell and on-cell nuclear magnetic resonance (NMR) spectroscopy is a powerful method that offers exciting new possibilities for structural and functional studies in and on live cells. In contrast to conventional imaging techniques, in- and on-cell NMR methods do not provide spatial information on cellular biomolecules. Instead, they enable atomic-resolution insights into the native cell states of proteins, nucleic acids, glycans, and lipids. Here we review recent advances and developments in both fields and discuss emerging concepts that have been delineated with these methods.

8 November 2018 in mAbs
Verified
Journal Article
Open access
RBRobert Brinson
Robert Brinson
JMJohn P. Marino
John P. Marino
FDFrank Delaglio
Frank Delaglio
LALuke W. Arbogast
Luke W. Arbogast
RERyan M. Evans
Ryan M. Evans
MWMats Wikström
Mats Wikström
The increased interest in using monoclonal antibodies (mAbs) as a platform for biopharmaceuticals has led to the need for new analytical techniques that can precisely assess physicochemical properties of these large and very complex drugs for the purpose of correctly identifying quality attributes (QA). One QA, higher order structure (HOS), is unique to biopharmaceuticals and essential for establishing consistency in biopharmaceutical manufacturing, detecting process-related variations from manufacturing changes and establishing comparability between biologic products. To address this measurement challenge, two-dimensional nuclear magnetic resonance spectroscopy (2D-NMR) methods were introduced that allow for the precise atomic-level comparison of the HOS between two proteins, including mAbs. Here, an inter-laboratory comparison involving 26 industrial, government and academic laboratories worldwide was performed as a benchmark using the NISTmAb, from the National Institute of Standards and Technology (NIST), to facilitate the translation of the 2D-NMR method into routine use for biopharmaceutical product development. Two-dimensional 1H,15N and 1H,13C NMR spectra were acquired with harmonized experimental protocols on the unlabeled Fab domain and a uniformly enriched-15N, 20%-13C-enriched system suitability sample derived from the NISTmAb. Chemometric analyses from over 400 spectral maps acquired on 39 different NMR spectrometers ranging from 500 MHz to 900 MHz demonstrate spectral fingerprints that are fit-for-purpose for the assessment of HOS. The 2D-NMR method is shown to provide the measurement reliability needed to move the technique from an emerging technology to a harmonized, routine measurement that can be generally applied with great confidence to high precision assessments of the HOS of mAb-based biotherapeutics.

29 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAikaterini Alexaki
Aikaterini Alexaki
GHGaya K. Hettiarachchi
Gaya K. Hettiarachchi
JAJohn C. Athey
John C. Athey
UKUpendra Katneni
Upendra Katneni
VSVijaya Simhadri
Vijaya Simhadri
CKChava Kimchi-Sarfaty
Chava Kimchi-Sarfaty
Synonymous codons occur with different frequencies in different organisms, a phenomenon termed codon usage bias. Codon optimization, a common term for a variety of approaches used widely by the biopharmaceutical industry, involves synonymous substitutions to increase protein expression. It had long been presumed that synonymous variants, which, by definition, do not alter the primary amino acid sequence, have no effect on protein structure and function. However, a critical mass of reports suggests that synonymous codon variations may impact protein conformation. To investigate the impact of synonymous codons usage on protein expression and function, we designed an optimized coagulation factor IX (FIX) variant and used multiple methods to compare its properties to the wild-type FIX upon expression in HEK293T cells. We found that the two variants differ in their conformation, even when controlling for the difference in expression levels. Using ribosome profiling, we identified robust changes in the translational kinetics of the two variants and were able to identify a region in the gene that may have a role in altering the conformation of the protein. Our data have direct implications for codon optimization strategies, for production of recombinant proteins and gene therapies.

1 May 2014 in Progress in Nuclear Magnetic Resonance Spectroscopy
Verified
Journal Article
Closed access
MBMarcos D. Battistel
Marcos D. Battistel
HAHugo F. Azurmendi
Hugo F. Azurmendi
BYBingwu Yu
Bingwu Yu
DFDarón I. Freedberg
Darón I. Freedberg

10 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HAHugo F. Azurmendi
Hugo F. Azurmendi
JVJustine Vionnet
Justine Vionnet
LWLauren Wrightson
Lauren Wrightson
LTLoc B. Trinh
Loc B. Trinh
JSJoseph Shiloach
Joseph Shiloach
DFDarón I. Freedberg
Darón I. Freedberg
The capsular polysaccharide of the pathogens Neisseria meningitidis serogroup B and of Escherichia coli K1, α(2 → 8) polysialic acid (PSA), is unusual, because when injected into adult humans, it generates little or no antibody. In contrast, people infected with these pathogens generate specific serum antibodies. A structural study on cells is used to address this anomaly by characterizing antigen structures in vivo . We introduce on cell multidimensional solution NMR spectroscopy for direct observation of PSA on E. coli bacteria. Using 13 C, 15 N-labeled PSA, we applied a combination of heteronuclear NMR methods, such as heteronuclear single quantum coherence, HNCA, and HNCO, in vivo . Analysis reveals that free and cell-bound PSA are structurally similar, indicating that the poor immunogenicity of PSA is not due to major structural differences between cells and purified PSA. The 13 C linewidths of PSA on cells are 2 to 3 times larger than the corresponding ones in free PSA. The possible implications of the differences between free and on cell PSA are discussed. In addition, we demonstrate the suitability of the method for in vivo kinetic studies.

12 April 2013 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
MBMarcos D. Battistel
Marcos D. Battistel
RPRobert Pendrill
Robert Pendrill
GWGoran Widmalm
Goran Widmalm
DFDarón I. Freedberg
Darón I. Freedberg